Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma

Archive ouverte

Saillard, Charlie | Delecourt, Flore | Schmauch, Benoit | Moindrot, Olivier | Svrcek, Magali | Bardier-Dupas, Armelle | Emile, Jean Francois | Ayadi, Mira | Rebours, Vinciane | de Mestier, Louis | Hammel, Pascal | Neuzillet, Cindy | Bachet, Jean Baptiste | Iovanna, Juan | Dusetti, Nelson | Blum, Yuna | Richard, Magali | Kermezli, Yasmina | Paradis, Valerie | Zaslavskiy, Mikhail | Courtiol, Pierre | Kamoun, Aurelie | Nicolle, Remy | Cros, Jerome

Edité par CCSD ; Nature Publishing Group -

International audience. Two tumor (Classical/Basal) and stroma (Inactive/active) subtypes of Pancreatic adenocarcinoma (PDAC) with prognostic and theragnostic implications have been described. These molecular subtypes were defined by RNAseq, a costly technique sensitive to sample quality and cellularity, not used in routine practice. To allow rapid PDAC molecular subtyping and study PDAC heterogeneity, we develop PACpAInt, a multi-step deep learning model. PACpAInt is trained on a multicentric cohort ( n = 202) and validated on 4 independent cohorts including biopsies (surgical cohorts n = 148; 97; 126 / biopsy cohort n = 25), all with transcriptomic data ( n = 598) to predict tumor tissue, tumor cells from stroma, and their transcriptomic molecular subtypes, either at the whole slide or tile level (112 µm squares). PACpAInt correctly predicts tumor subtypes at the whole slide level on surgical and biopsies specimens and independently predicts survival. PACpAInt highlights the presence of a minor aggressive Basal contingent that negatively impacts survival in 39% of RNA-defined classical cases. Tile-level analysis ( > 6 millions) redefines PDAC microheterogeneity showing codependencies in the distribution of tumor and stroma subtypes, and demonstrates that, in addition to the Classical and Basal tumors, there are Hybrid tumors that combine the latter subtypes, and Intermediate tumors that may represent a transition state during PDAC evolution.

Suggestions

Du même auteur

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach

Archive ouverte | Hilmi, Marc | CCSD

International audience. Pancreatic ductal adenocarcinoma (PDAC) tumor interpatient heterogeneity has been well described with two major prognostic subtypes (classical and basal‐like). An important intrapatient heter...

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma

Archive ouverte | Jiang, Lingxi | CCSD

International audience. © The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.Adjuvant chemotherapy benefits patients with resected pancreatic ductal adenocarcinoma (PDAC), but the compromis...

Redefining phenotypic heterogeneity of pancreatic ductal adenocarcinoma: A bottom-up approach

Archive ouverte | Hilmi, Marc | CCSD

International audience. Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) tumor inter-patient heterogeneity has been well described with two major subtypes (classical and basal-like). An imp...

Chargement des enrichissements...